These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 30417404

  • 1. Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction.
    Horn R, Bamford NJ, Afonso T, Sutherland M, Buckerfield J, Tan RHH, Secombe CJ, Stewart AJ, Bertin FR.
    Equine Vet J; 2019 Jul; 51(4):440-445. PubMed ID: 30417404
    [Abstract] [Full Text] [Related]

  • 2. BEVA primary care clinical guidelines: Diagnosis and management of equine pituitary pars intermedia dysfunction.
    Menzies-Gow NJ, Banse HE, Duff A, Hart N, Ireland JL, Knowles EJ, McFarlane D, Rendle D.
    Equine Vet J; 2024 Mar; 56(2):220-242. PubMed ID: 37795557
    [Abstract] [Full Text] [Related]

  • 3. Lamellar pathology in horses with pituitary pars intermedia dysfunction.
    Karikoski NP, Patterson-Kane JC, Singer ER, McFarlane D, McGowan CM.
    Equine Vet J; 2016 Jul; 48(4):472-8. PubMed ID: 25869529
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis.
    Donaldson MT, Jorgensen AJ, Beech J.
    J Am Vet Med Assoc; 2004 Apr 01; 224(7):1123-7. PubMed ID: 15074858
    [Abstract] [Full Text] [Related]

  • 5. Association between hyperinsulinaemia and laminitis severity at the time of pituitary pars intermedia dysfunction diagnosis.
    Tadros EM, Fowlie JG, Refsal KR, Marteniuk J, Schott HC.
    Equine Vet J; 2019 Jan 01; 51(1):52-56. PubMed ID: 29761574
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of pituitary pars intermedia dysfunction and Prascend (pergolide tablets) treatment on endocrine and immune function in horses.
    Miller AB, Loynachan AT, Bush HM, Hart KA, Barker VD, Campana-Emard AG, Grubbs ST, Adams AA.
    Domest Anim Endocrinol; 2021 Jan 01; 74():106531. PubMed ID: 32942194
    [Abstract] [Full Text] [Related]

  • 13. Effects of advanced age and pituitary pars intermedia dysfunction on components of the acute phase reaction in horses.
    Zak A, Siwinska N, Elzinga S, Barker VD, Stefaniak T, Schanbacher BJ, Place NJ, Niedzwiedz A, Adams AA.
    Domest Anim Endocrinol; 2020 Jul 01; 72():106476. PubMed ID: 32380311
    [Abstract] [Full Text] [Related]

  • 14. Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction.
    Fortin JS, Benskey MJ, Lookingland KJ, Patterson JS, Howey EB, Goudreau JL, Schott HC.
    BMC Vet Res; 2020 Sep 25; 16(1):356. PubMed ID: 32977825
    [Abstract] [Full Text] [Related]

  • 15. Equine pituitary pars intermedia dysfunction: current understanding and recommendations from the Australian and New Zealand Equine Endocrine Group.
    Secombe CJ, Bailey SR, de Laat MA, Hughes KJ, Stewart AJ, Sonis JM, Tan R.
    Aust Vet J; 2018 Jul 25; 96(7):233-242. PubMed ID: 29862508
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Investigation of single and paired measurements of adrenocorticotropic hormone for the diagnosis of pituitary pars intermedia dysfunction in horses.
    Rendle DI, Duz M, Beech J, Parkin T, Durham AE.
    J Vet Intern Med; 2015 Jan 25; 29(1):355-61. PubMed ID: 25312676
    [Abstract] [Full Text] [Related]

  • 18. Endocrinopathic Laminitis.
    Grenager NS.
    Vet Clin North Am Equine Pract; 2021 Dec 25; 37(3):619-638. PubMed ID: 34674908
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis.
    de Laat MA, Sillence MN, Reiche DB.
    J Vet Intern Med; 2019 May 25; 33(3):1456-1463. PubMed ID: 30697823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.